High-dose pilot studies in extensive-stage small-cell lung cancer

David H. Johnson, Kenneth R. Hande, Lester L. Porter, John D. Hainsworth, Steven N. Wolff, F. Anthony Greco

Research output: Contribution to journalArticlepeer-review


Small-cell lung cancer is rarely cured with standard chemotherapy, despite initial good responses. The concept of high-dose induction therapy for extensive-stage patients has been explained in a series of pilot studies. The rationale of this approach and the most recent preliminary results will be presented.

Original languageEnglish (US)
Pages (from-to)37-39
Number of pages3
JournalSeminars in oncology
Issue number3 SUPPL. 3
StatePublished - Sep 1986

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'High-dose pilot studies in extensive-stage small-cell lung cancer'. Together they form a unique fingerprint.

Cite this